Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

ChiNext Qianhai Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$30M
Portfolio companies 1
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
Summary

The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are Shenzhen Capital Group, Junchenda Capital.

The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.

Among the most successful fund investment fields, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Hrain Biotechnology

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
A15 Al Qahirah, Cairo, Egypt
Ajax Strategies Missouri, St Louis, United States
Ambridge Capital -
AsiaTech Management California, Cupertino, United States
Australian Government Australia, Australian Capital Territory, Canberra
Binghong Chuangye China, Henan, Zhengzhou
Brandless California, San Francisco, United States
Broadwing Communication Austin, Texas, United States
China Oceanwide Beijing, Beijing, China
Chongyisheng -
DHC Software Beijing, Beijing, China
Dutch Good Growth Fund -
INNOventure Kraków, Malopolskie, Poland
Jieliyuan Group -
Leyi Venture Capital China, Shanghai
National Bank of Greece Athens, Attica, Greece
Request Central, Central Region, Singapore
Sprott Asset Management Canada, Ontario, Toronto
The Associated Press New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Health Care
$30M30 Sep 2019 Shanghai

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ChiNext Qianhai Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: